Target intelligence / Profile preview

MicroRNA 302e (miR-302e)

Target
miR-302e
Molecular classification
MicroRNA, Non-coding RNA, Small RNA
01

Overview

MicroRNA 302e is a member of the miR-302 family, consisting of small, non-coding RNA molecules (approximately 19–25 nucleotides) that regulate gene expression post-transcriptionally by binding to complementary sequences on target mRNAs, resulting in translational repression or mRNA degradation. The miR-302 family is highly expressed in embryonic stem cells and is involved in maintaining pluripotency and regulating the cell cycle. Dysregulation of this family, including miR-302e, has been implicated in cancer progression, stem cell reprogramming, and possibly in cardiovascular disease. Although miR-302e itself is not directly targeted by any approved drugs, microRNAs as a class are being explored for their therapeutic and biomarker potential, particularly in oncology and regenerative medicine[2].

Other names
hsa-miR-302eMIRN302Ehsa-mir-302eMIR302E
02

Mechanism of action

MicroRNA 302e binds to complementary sequences on messenger RNAs (mRNAs), leading to repression of translation or degradation of the target mRNAs[2]

03

Biological functions

Post-transcriptional gene regulationCell cycle regulationCell proliferationEmbryonic stem cell maintenanceCellular reprogramming
04

Disease associations

CancerPotentially cardiovascular disease (explored, limited evidence)Other (implicated in stem cell biology and tissue regeneration)
05

Safety considerations

Off-target effects due to broad gene regulationPotential disturbance in stem cell or developmental programsDelivery and stability in vivo (if used as therapeutic target or agent) remain challenging[2]
06

Biomarkers

miR-302e may serve as a biomarker for certain cancers (such as its family being explored in cancer and stem cell biology)

Beyond the preview

Go deeper on MicroRNA 302e (miR-302e).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 302e (miR-302e).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call